Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
There are more than 10 dozen anti-HIV drugs in the developmental pipeline that pharmaceutical manufacturers and other research institutions are working on; that's roughly 50% more than were being worked on a year ago. The entry inhibitor category continues to show strong promise with 40 candidates'15 more than this time last year. Entry Inhibitors (Medication Name, Stage of Development, Developer) ' 15D, Preclinical, National Cancer Institute ' 15K, Preclinical, National Cancer Institute ' AK602, Phase I, Kumamoto University ' AMD3451 CCR5-CXCR4 blocker), Preclinical, Anormed ' Betulinic acid derivatives; Preclinical; University of North Carolina, Duke University, Vanderbilt University ' BMS-378806 (gp120 blocker), Phase I, Bristol-Myers Squibb ' CCR5mAb004 (CCR5 blocker), Preclinical, Human Genome Sciences ' D5 (artificial gp41 blocker), Preclinical, Merck ' DP-178 (fusion inhibitor), Preclinical, Weizmann Institute ' GBV-C (virus increases chemokines, including CCR5 blockers), Preclinical, University of Iowa ' gp41 inhibitor, Preclinical, New York Blood Center ' gp41 inhibitor, Preclinical, Locus Pharmaceuticals ' gp120-gp41 disulfide bond; Preclinical; Amsterdam Mathematical Center, Cornell University, University of Illinois at Chicago ' IC9564, Preclinical, Duke University ' Indolicidin, Preclinical,National Institutes of Health ' KD-247 (CCR5 blocker), Preclinical, Kumamoto University ' KRH-2731 (CXCR4 blocker), Preclinical, Kureha ''KRH-3140 (CXCR4 blocker), Preclinical, Kureha ' KRH-3955 (CXCR4 blocker), Preclinical, Kureha ''Maraviroc/UK-427 (CCR5 blocker), Phase III, Pfizer ''MDX-010, Preclinical, Medarex ' Monoclonal FAbs (gp41 blocker), Preclinical, National Institutes of Health ''NB-2 (gp41 blocker), Preclinical, Shibo and Kumar ' NB-64 (gp41 blocker), Preclinical, Shibo and Kumar ''NSC 13778 (gp120 blocker), Preclinical, SAIC-National Cancer Institute ' PRO-140 (monoclonal antibody), Phase I, Progenics ' Pyrrolidine (CCR5 blocker), Preclinical, Merck ' RANTES analogs (CCR5 blockers), Preclinical, University of Geneva ' RC-112, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Retrocyclin-1, Preclinical, CDC's AIDS, STD, and TB Laboratory Research ' Sifuvirtide, Preclinical, Fusogen ' SP-01 A, Preclinical, Samaritan ' SP-10, Preclinical, Samaritan ' TAK-652 (CCR5 blocker), Preclinical, Takeda ' TNX-355 (monoclonal antibody), Phase II, Tanox and Biogen ' TR-999, Preclinical, Trimeris and Roche ' TR-1144, Preclinical, Trimeris and Roche ' UMIST, Preclinical, Genetic Innovation Network ' Vicriviroc/SCH-D (CCR5 blocker), Phase II, Schering Plough ' Zinc finger protein nucleases (CCR5 blockers), Preclinical, Sangamo Biosciences Integrase Inhibitors(Medication Name, Stage of Development, Developer) ' AVX-I, Preclinical, Avexa ' Beta-diketo acids, Preclinical, University of Parma and University of Sassari ' Carbazole derivative, Preclinical, Japan's National Institute of Infectious Diseases ' GSK-810871, Preclinical, GlaxoSmithKline ' Indolicidin, Preclinical, National Cancer Institute ' GS-9137 (JTK-303), Phase II, Gilead Sciences and Japan Tobacco ' ITI-367, Preclinical, George Washington University ' L-second generation, Preclinical, Merck ' MK-0518, Phase III, Merck ' Monophores, Preclinical, Sunesis ' Mycelium integrasone (fungal polyketide), Preclinical, Merck ' PL-2500, Preclinical, Procyon Biopharma ' Styrylquinoline derivatives, Preclinical, BioAlliance Pharma ' Theophyline, Preclinical, Thomas Jefferson University ' V-165, Preclinical, Rega Institute Maturation Inhibitors(Medication Name, Stage of Development, Developer) ' Alpha HGA, Phase I, Tripep ' Betulinic acid derivatives (entry, maturation inhibitors); Preclinical; University of North Carolina, Duke University, Vanderbilt University ' Chloroquine, Preclinical, Catholic University of Rome ' enJS56A1, Preclinical, University of Georgia ' PA-457 (capsid inhibitor), Phase II, Vitex ' RPI-MN, Preclinical, ReceptoPharm ' UK-201844, Preclinical, Pfizer Nonnucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' BILR 355 BS, Phase I/II, Boehringer-Ingelheim ' DOT (dioxolane thymidine), Phase I, University of Georgia ' GS9148, Preclinical, Gilead Sciences ' GSK-695634, Phase I, GlaxoSmithKline ' MIV-170, Preclinical, Medivir ' NVP C-8 substituent, Preclinical, Boehringer-Ingelheim ' Oligodeoxi-nucleotides, Preclinical, University of Zurich ' PBO-15c (pyrrolobenzoxazepinone), Preclinical, University of Siena ' Phenylthiazoylamines, Preclinical, Yale University ' Pyridinone derivatives, Preclinical, Rutgers University ' Quinolones, Preclinical, Wellcome Trust ' S-DABO derivatives, Preclinical, China's Fudan University ' SMP-610, Preclinical, Advanced Life Sciences ' SMP-717, Preclinical, Advanced Life Sciences ' Thiazol derivatives, Preclinical, Japan's Institute for Virus Research ' TMC-125 (etravirine), Phase III, Tibotec and Johnson & Johnson ' TMC-278 (diarylpyrimidine or DAPY), Phase II, Tibotec ' Tricyclic NNRTI, Preclinical, Bristol-Myers Squibb Nucleoside Reverse Transcriptase Inhibitors(Medication Name, Stage of Development, Developer) ' 4-Ed4T, Preclinical, Kagoshima University ' AVX754, Phase I/II, Avexa ' BPH-218, Preclinical, University of Pittsburgh ' Branched 3 primers, Preclinical, University of Illinois ' Compound X, Preclinical, Tibotec ' D-FDOC, Preclinical, Emory University ' Dinucleoside polyphosphates, Preclinical, University of Miami ' DOT-TP, Preclinical, Emory University ' dTTP, Preclinical, University of Rochester ' E2-FdA, Preclinical, Kumamoto University ' Elvucitabine (ACH-126), Phase II, Achillion ' Herpesvirus saimiri, Preclinical, Temple University ' KMMP05, Preclinical, National Cancer Institute ' KP-1461, Phase I/II, Koronis ' Racivir, Phase I/II, Pharmasset ' Stampidine, Preclinical, Parker Hughes Institute ' Thiovir, Preclinical, Adventrx ' Triol, Preclinical, Cruz Foundation Protease Inhibitors(Medication Name, Stage of Development, Developer) ' A-681799, Preclinical, Abbott Laboratories ' Beta-lactams, Preclinical, University of Debrecen ' Brecanavir (GSK-640385), Phase II, GlaxoSmithKline ' GRL-02031, Preclinical, Kumamoto University ' PPL-100, Preclinical, Procyon Biopharma ' SPI-256, Preclinical, Sequoia ' UIC02031, Preclinical, Kumamoto University Others(Medication Name, Stage of Development, Developer) ' Alpha-v integrins, Preclinical, irsiCaixa Foundation and Merck ' BL-1050 (regulatory protein inhibitor), Preclinical, BioLine Rx ' CDK inhibitor, Preclinical, Gilead Sciences ' CNI-1493 (rev inhibitor), Preclinical, Heinrich Pette Institute ' Curcumin/diferuloylmethane (tat inhibitor), Preclinical, Jawaharlal Nehru Center ' Cycloamides, Phase I, University of Illinois ' Glycodendrimers (lipid raft carbohydrates), Preclinical, Penn State University ' HRG214 (caprine IgG), Preclinical, Virionyx ' IM (CDK9 inhibitor), Preclinical, Institute of Human Virology ' KU-55933 (ATM kinase inhibitor), Preclinical, Kudos Pharma ' MDI-P (electrolyzed free radical), Preclinical, Medical Discoveries ' Mifepristone (glucocorticoid antagonist), Phase I, University of Pittsburgh ' Oxadiazols (nuclear localization viral matrix blockers), Preclinical, International Therapeutics ' Poly acrylic acid, Preclinical, Chinese Academy of Science ' Resveretrol (Egr1 gene activator), Preclinical, National Cancer Institute ' Rev inhibitors, Preclinical, National Institutes of Health ' RPI (nicotinic acetylcholine receptor blocker), Preclinical, NutraPharma ' RSC-1838, Preclinical, GlaxoSmithKline and Shionogi ' RWJ67567 (p38 inhibitor), Preclinical, University of Pennsylvania and Johnson & Johnson ' siRNA constructs (rev/tat inhibitors), Preclinical, Beckman Institute ' siRNA molecule, Preclinical, CombiMatrix ' TRIM5-alpha (capsid inhibitor), Preclinical, Dana Farber Cancer Institute-NIAID
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Plus: Featured Video
Latest Stories
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM